ECM
INR 4.3 bn
FY25
Book Running Lead Manager for QIP of PDS Limited
Ambit acted as the BRLM to INR 4.3 bn QIP of PDS Limited. Ambit played a critical role in shaping investors’ understanding of the opportunity provided by PDS.
Book Running Lead Manager for QIP of PDS Limited
Ambit acted as the BRLM to INR 4.3 bn QIP of PDS Limited. Ambit played a critical role in shaping investors’ understanding of the opportunity provided by PDS.
ECM
INR 6 bn
FY25
Left Lead BRLM for IPO of Interarch Building Products Limited
Ambit, as the Left Lead BRLM, anchored the end-to-end execution process and guided the company through its IPO journey
Left Lead BRLM for IPO of Interarch Building Products Limited
Ambit, as the Left Lead BRLM, anchored the end-to-end execution process and guided the company through its IPO journey
ECM
INR 18 bn
FY25
Broker to KKR for sale of c. 17% stake in India Grid Trust
Ambit acted as a Broker to the Offer For Sale for KKR with an approximate issue size of c. INR 1,800 cr (including Green Shoe of c. INR 800 cr). Ambit played a pivotal role in mobilizing Institutional & Family Offices/HNI demand with 1.9x subscription in the non-retail portion, incl. marquee domestic and foreign investors.
Broker to KKR for sale of c. 17% stake in India Grid Trust
Ambit acted as a Broker to the Offer For Sale for KKR with an approximate issue size of c. INR 1,800 cr (including Green Shoe of c. INR 800 cr). Ambit played a pivotal role in mobilizing Institutional & Family Offices/HNI demand with 1.9x subscription in the non-retail portion, incl. marquee domestic and foreign investors.
ECM
INR 18.6 bn
FY25
Book Running Lead Manager for IPO of Akums Drugs and Pharmaceuticals Limited
Ambit acted as a Book running lead manager to the INR 18.6 bn IPO consisting a Fresh Issue of INR 6.8 bn and an Offer for Sale of INR 11.8 bn.
The IPO received overwhelming response across categories with the overall mainbook subscription of ~63x and the QIB, HNI and Retail portions getting subscribed ~90x, ~42x and ~21x respectively.
Book Running Lead Manager for IPO of Akums Drugs and Pharmaceuticals Limited
Ambit acted as a Book running lead manager to the INR 18.6 bn IPO consisting a Fresh Issue of INR 6.8 bn and an Offer for Sale of INR 11.8 bn.
The IPO received overwhelming response across categories with the overall mainbook subscription of ~63x and the QIB, HNI and Retail portions getting subscribed ~90x, ~42x and ~21x respectively.
Capital Raise
NA
FY25
Acted as the exclusive financial advisor to greytHR on its strategic investment from Apax Digital Fund
Ambit acted as the exclusive financial advisor to Greytip Software Private Limited (“greytHR”) on its strategic investment from Apax Digital Fund
Acted as the exclusive financial advisor to greytHR on its strategic investment from Apax Digital Fund
Ambit acted as the exclusive financial advisor to Greytip Software Private Limited (“greytHR”) on its strategic investment from Apax Digital Fund
M&A
INR 3.7 bn
FY25
Exclusive advisor to Times Internet for sale of ET Money to 360 ONE WAM
Ambit acted as an exclusive financial advisor to Times Internet for sale of ET Money to 360 ONE WAM, through a stock and cash deal.
Exclusive advisor to Times Internet for sale of ET Money to 360 ONE WAM
Ambit acted as an exclusive financial advisor to Times Internet for sale of ET Money to 360 ONE WAM, through a stock and cash deal.
M&A
INR 28.4 bn
FY25
Sale of a portfolio of 7 road assets to Cube InvIT by Cube Highways and Infrastructure III Pte Ltd.
Ambit acted as an exclusive financial advisor to Cube Highways and Infrastructure III Pte Ltd. on their 100% stake sale in seven road assets to Cube Highways Trust (“Cube InvIT”).
Sale of a portfolio of 7 road assets to Cube InvIT by Cube Highways and Infrastructure III Pte Ltd.
Ambit acted as an exclusive financial advisor to Cube Highways and Infrastructure III Pte Ltd. on their 100% stake sale in seven road assets to Cube Highways Trust (“Cube InvIT”).
Capital Raise
USD 20 mn
FY25
Exclusive advisor to Orbicular Pharmaceutical Technologies Pvt. Ltd. Technologies on its growth capital fund raise
Ambit acted as the exclusive financial advisor to Orbicular on its growth capital fund raise of USD 20 Mn led by Tata Capital Healthcare Fund
Exclusive advisor to Orbicular Pharmaceutical Technologies Pvt. Ltd. Technologies on its growth capital fund raise
Ambit acted as the exclusive financial advisor to Orbicular on its growth capital fund raise of USD 20 Mn led by Tata Capital Healthcare Fund
M&A
INR 27 bn
FY25
Sale of Investor stake in L&T Infrastructure Development Projects Limited (L&T IDPL)
Ambit acted as the sole and exclusive financial adviser to CPP Investments for sale of their 49% stake in L&T Infrastructure Development Projects Limited (L&T IDPL) to portfolio company of a fund managed by Edelweiss Alternative Asset Advisors Limited
Sale of Investor stake in L&T Infrastructure Development Projects Limited (L&T IDPL)
Ambit acted as the sole and exclusive financial adviser to CPP Investments for sale of their 49% stake in L&T Infrastructure Development Projects Limited (L&T IDPL) to portfolio company of a fund managed by Edelweiss Alternative Asset Advisors Limited